# US 2024/0002929 A1 · Methods and systems for processing polynucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002929 A1
- Document ID: US20240002929A1
- Status: Published application
- Kind: A1
- Application number: 18/186,088
- Filed: 2023-03-17
- Published: 2024-01-04
- Earliest claimed: 2012-08-14
- Assignees: 10x Genomics, Inc.
- Applicants: 10x Genomics, Inc.
- Inventors: Christopher Hindson; Michael Schnall-Levin; Andrew Price; Paul Hardenbol; Yuan Li
- Web page: https://patentgrep.com/patent/US20240002929A1

## CPC

- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6855: Ligating adaptors
- C12Q 1/6869: Methods for sequencing
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

This disclosure provides methods and compositions for sample processing, particularly for sequencing applications. Included within this disclosure are bead compositions, such as diverse libraries of beads attached to large numbers of oligonucleotides containing barcodes. Often, the beads provides herein are degradable. For example, they may contain disulfide bonds that are susceptible to reducing agents. The methods provided herein include methods of making libraries of barcoded beads as well as methods of combining the beads with a sample, such as by using a microfluidic device.

## Claims

### Claim at position 1

1-27. (canceled)

### Claim 28

A method for nucleic acid processing, comprising:
(a) providing a plurality of partitions, wherein a partition of the plurality of partitions comprises a nucleic acid molecule comprising an epigenetic feature, and a nucleic acid barcode molecule comprising a barcode sequence;
(b) in the partition, using the nucleic acid molecule and the nucleic acid barcode molecule to generate a barcoded nucleic acid molecule, wherein the barcoded nucleic acid molecule comprises the barcode sequence or complement thereof;
(c) processing the barcoded nucleic acid molecule or derivative thereof to identify the epigenetic feature and the barcode sequence; and
(d) using the epigenetic feature and the barcode sequence to determine an epigenetic state associated with the nucleic acid molecule.

### Claim 29 (depends on 28)

The method of claim 28, wherein (d) comprises sequencing the barcoded nucleic acid molecule or derivative thereof to provide sequencing data.

### Claim 30 (depends on 28)

The method of claim 28, wherein the epigenetic feature comprises methylation of the nucleic acid molecule.

### Claim 31 (depends on 28)

The method of claim 28, further comprising, prior to (a), treating the nucleic acid molecule with bisulfite, wherein the treating converts at least a portion of unmethylated cytosines of the nucleic acid molecule to uracil.

### Claim 32 (depends on 28)

The method of claim 28, further comprising, prior to (a), splitting a biological sample comprising the nucleic acid molecule into a plurality of aliquots, wherein a first aliquot of the plurality of aliquots is treated with bisulfite and comprises the nucleic acid molecule, and wherein a second aliquot of the plurality of aliquots is not treated with bisulfite.

### Claim 33 (depends on 32)

The method of claim 32, wherein (d) comprises sequencing the barcoded nucleic acid molecule or derivative thereof to provide sequencing data.

### Claim 34 (depends on 32)

The method of claim 32, further comprising generating an additional barcoded nucleic acid molecule from an additional nucleic acid molecule of the second aliquot and sequencing the additional nucleic acid barcode molecule or derivative thereof to provide additional sequencing data.

### Claim 35 (depends on 34)

The method of claim 34, wherein (d) comprises comparing the sequencing data with the additional sequencing data.

### Claim 36 (depends on 28)

The method of claim 28, further comprising, prior to (a), treating the nucleic acid molecule or derivative thereof with a methylation specific restriction enzyme (MSRE), wherein the treating cleaves the nucleic acid molecule at one or more methylation sites.

### Claim 37 (depends on 28)

The method of claim 28, further comprising, prior to (a), splitting a biological sample comprising the nucleic acid molecule into a plurality of aliquots, wherein a first aliquot of the plurality of aliquots is treated with a methylation specific restriction enzyme (MSRE), and wherein a second aliquot of the plurality of aliquots is not treated with the MSRE.

### Claim 38 (depends on 28)

The method of claim 28, wherein the partition comprises a cell, and wherein the cell comprises the nucleic acid molecule.

### Claim 39 (depends on 38)

The method of claim 38, wherein the cell is encapsulated in a bead.

### Claim 40 (depends on 39)

The method of claim 39, further comprising, prior to (a), encapsulating the cell in a polymer matrix, wherein the encapsulating generates the bead.

### Claim 41 (depends on 39)

The method of claim 39, further comprising, prior to (a), performing a gelation reaction to produce the bead.

### Claim 42 (depends on 38)

The method of claim 38, wherein the bead comprises one or more reagents for processing the nucleic acid molecule.

### Claim 43 (depends on 38)

The method of claim 38, further comprising, during or subsequent to (a), lysing the cell to release the nucleic acid molecule into the partition.

### Claim 44 (depends on 43)

The method of claim 43, further comprising, subsequent to the lysing, treating the nucleic acid molecule with one or more proteases.

### Claim 45 (depends on 28)

The method of claim 28, further comprising, in (a), providing a bead in the partition, wherein the bead comprises the nucleic acid barcode molecule.

### Claim 46 (depends on 45)

The method of claim 45, wherein the nucleic acid barcode molecule is releasably coupled to the bead.

### Claim 47 (depends on 46)

The method of claim 46, wherein the nucleic acid barcode molecule is releasably coupled to the bead via a labile moiety.

### Claim 48 (depends on 47)

The method of claim 47, wherein the labile moiety is a chemically labile moiety.

### Claim 49 (depends on 48)

The method of claim 48, wherein the chemically labile moiety is a disulfide bond.

### Claim 50 (depends on 47)

The method of claim 47, further comprising, after (a), releasing the nucleic acid barcode molecule from the bead by application of a stimulus to the bead.

### Claim 51 (depends on 50)

The method of claim 50, wherein the stimulus is a chemical stimulus.

### Claim 52 (depends on 51)

The method of claim 51, wherein the chemical stimulus is in the partition.

### Claim 53 (depends on 51)

The method of claim 51, wherein the chemical stimulus is a reducing agent.

### Claim 54 (depends on 53)

The method of claim 53, wherein the reducing agent is dithiothreitol (DTT).

### Claim 55 (depends on 28)

The method of claim 28, wherein the plurality of partitions is a plurality of wells.

### Claim 56 (depends on 28)

The method of claim 28, wherein the plurality of partitions is a droplet.

### Claim 57 (depends on 28)

The method of claim 28, wherein (b) comprises performing a nucleic acid extension reaction using the nucleic acid barcode molecule and the nucleic acid molecule.
